Lopes J, Rodrigues C, Gaspar M, Reis C (2022) Melanoma management: from epidemiology to treatment and latest advances. Cancers 14:4652

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rozeman EA, Dekker TJ, Haanen JB, Blank CU (2018) Advanced melanoma: current treatment options, biomarkers, and future perspectives. Am J Clin Dermatol 19(3):303–317

Article  PubMed  Google Scholar 

Domingues B, Lopes JM, Soares P, Pópulo H (2018) Melanoma treatment in review. ITT: 35–49

Azem O, Nabulsi O, Jelinek M, Joshi N (2024) Radiation therapy in the management of head and neck mucosal melanoma. Cancers 16(19):3304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haussmann J, Corradini S, Nestle-Kraemling C, Bölke E, Njanang FJD, Tamaskovics B, Orth K, Ruckhaeberle E, Fehm T, Mohrmann S (2020) Recent advances in radiotherapy of breast cancer. Radiat Oncol 15(1):71

Article  PubMed  PubMed Central  Google Scholar 

Milam RW Jr, Batson SA, Breazzano MP, Ayala-Peacock DN, Daniels AB (2017) Modern and novel radiotherapy approaches for the treatment of uveal melanoma. Int Ophthalmol Clin 57(1):11–27

Article  PubMed  Google Scholar 

Espenel S, Vallard A, Rancoule C, Garcia M‑A, Guy J‑B, Chargari C, Deutsch E, Magné N (2017) Melanoma: Last call for radiotherapy. Crit Rev Oncol Hematol 110:13–19

Article  PubMed  Google Scholar 

Cohen-Inbar O, Shih H‑H, Xu Z, Schlesinger D, Sheehan JP (2017) The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. JNS 127(5):1007–1014

Article  Google Scholar 

Henderson MA, Burmeister BH, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S (2015) Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6‑year follow-up of a phase 3, randomised controlled trial. Lancet Oncol 16(9):1049–1060

Article  PubMed  Google Scholar 

Tagliaferri L, Lancellotta V, Fionda B, Mangoni M, Casà C, Di Stefani A, Pagliara MM, D’Aviero A, Schinzari G, Chiesa S (2022) Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review. Hum Vaccines Immunother 18(3):1903827

Article  Google Scholar 

Ge Y, Che X, Gao X, Zhao S, Su J (2021) Combination of radiotherapy and targeted therapy for melanoma brain metastases: a systematic review. Melanoma Res 31(5):413–420

Article  CAS  PubMed  Google Scholar 

Popovic M, Ahmed IIK, DiGiovanni J, Shields CL (2017) Radiotherapeutic and surgical management of iris melanoma: a review. Surv Ophthalmol 62(3):302–311

Article  PubMed  Google Scholar 

Testori A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A (2009) Eggermont AMM. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol 20:vi22–vi29

Article  PubMed  PubMed Central  Google Scholar 

Hendrickx A, Cozzio A, Plasswilm L, Panje CM (2020) Radiotherapy for lentigo maligna and lentigo maligna melanoma—a systematic review. Radiat Oncol 15(1):174

Article  PubMed  PubMed Central  Google Scholar 

Grant-Freemantle MC, O’Neill LB, Clover AJP (2021) The effectiveness of radiotherapy in the treatment of head and neck mucosal melanoma: systematic review and meta-analysis. Head & Neck 43(1):323–333

Article  Google Scholar 

Hallock A, Vujovic O, Yu E (2011) Is radiotherapy an effective treatment option for recurrent metastatic malignant melanoma? A case report of short-course, large-fraction radiation and a literature review. Can J Plast Surg 19(4):153–155

Article  PubMed  PubMed Central  Google Scholar 

Ahmed K, Stallworth D, Kim Y, Johnstone P, Harrison L, Caudell J, Yu H, Etame A, Weber J, Gibney G (2016) Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. Ann Oncol 27(3):434–441

Article  CAS  PubMed  Google Scholar 

Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, Vardy JL, Nowak AK, Dhillon HM, Ahmed T (2019) Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial. J Clin Oncol 37(33):3132–3141

Article  CAS  PubMed  Google Scholar 

Rogers SJ, Puric E, Eberle B, Datta NR, Bodis SB (2019) Radiotherapy for melanoma: More than DNA damage. Dermatol Res Pract 2019(1):9435389

PubMed  PubMed Central  Google Scholar 

Weber-Levine C, Jiang K, Al-Mistarehi A‑H, Welland J, Hersh AM, Horowitz MA, Davidar AD, Sattari SA, Redmond KJ, Lee SH (2025) The role of combination surgery and radiotherapy in patients with metastatic spinal cord compression: What are the remaining grey areas? A systematic review. Clin Neurol Neurosurg 248:108632

Article  PubMed  Google Scholar 

Sia J, Szmyd R, Hau E, Gee HE (2020) Molecular mechanisms of radiation-induced cancer cell death: a primer. Front Cell Dev Biol 8:41

Article  PubMed  PubMed Central  Google Scholar 

Dharanipragada P, Zhang X, Liu S, Lomeli SH, Hong A, Wang Y, Yang Z, Lo KZ, Vega-Crespo A, Ribas A (2023) Blocking genomic instability prevents acquired resistance to MAPK inhibitor therapy in melanoma. Cancer Discov 13(4):880–909

Article  PubMed  PubMed Central  Google Scholar 

Boulefour W, Rowinski E, Louati S, Sotton S, Wozny A‑S, Moreno-Acosta P, Mery B, Rodriguez-Lafrasse C, Magne N (2021) A review of the role of hypoxia in radioresistance in cancer therapy. Med Sci Monit Int Med J Exp Clin Res 27:e934116–934111

CAS  Google Scholar 

Trappetti V, Fazzari JM, Fernandez-Palomo C, Scheidegger M, Volarevic V, Martin OA, Djonov VG (2021) Microbeam radiotherapy—a novel therapeutic approach to overcome radioresistance and enhance anti-tumour response in melanoma. Int J Mol Sci 22(14):7755

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Wolf K, Kruse V, Sundahl N, Van Gele M, Chevolet I, Speeckaert R, Brochez L, Ost P (2017) A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response. J Transl Med 15(1):21

Article  PubMed  PubMed Central  Google Scholar 

van Beek JG, Ramdas WD, Angi M, van Rij CM, Naus NC, Kacperek A, Errington RD, Damato B, Heimann H, Kiliç E (2021) Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma. Radiother Oncol 157:219–224

Article  PubMed  Google Scholar 

Ashrafizadeh M, Farhood B, Musa AE, Taeb S, Najafi M (2020) The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives. Int Immunopharmacol 87:106807

Article  CAS  PubMed  Google Scholar 

Wang J, Wang Y, Jiang X (2024) Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals. J Drug Target 32(9):1052–1072

Article  CAS  PubMed  Google Scholar 

Huang R‑X, Zhou P‑K (2020) DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther 5(1):60

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng T, Sun C, Yun C, Wang H, Liu X (2025) Unlocking the Therapeutic Potential of DNA-PKcs in Cancer: Comprehensive Insights into Mechanisms and Clinical Applications. Cancers 17(17):2787

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun C, Chu A, Song R, Liu S, Chai T, Wang X, Liu Z (2023) PARP inhibitors combined with radiotherapy: are we ready? Front Pharmacol 14:1234973

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattacharya P, Shetake NG, Pandey BN, Kumar A (2018) Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization. Int J Radiat Biol 94(7):628–644

Article  CAS